Jonathan Soll
New Rhein Healthcare Investors
analyst
BioTech, Consumer Health, Diagnostics, Digital Health, Diverse Investors, Drug Delivery, Medical Devices, New York City, Pharmaceuticals, Therapeutics
investment
$20,000,000.00 - $50,000,000.00
analyst
BioTech, Consumer Health, Diagnostics, Digital Health, Diverse Investors, Drug Delivery, Medical Devices, New York City, Pharmaceuticals, Therapeutics
$20,000,000.00 - $50,000,000.00
